We revealed the entire landscape of pathway alterations in breast cancer, which exhibited high mutation frequencies in the p53 (55%), PI3K (45%), RTK-RAS (32%), and Notch (17%) pathways (Fig. 4a). Here, PIK3CA is linked to breast cancer.